1,000 Volunteers Enrolling at Stanford for COVID-19 Vaccine Trial
Nov. 3—Stanford Medicine has begun enrolling volunteers to participate in a clinical trial for a coronavirus vaccine developed by Johnson & Johnson — one of a handful of efforts considered front-runners in the global race for a vaccine.
Enrollment for Phase 3 of the trial began Friday, marking the final stage before potential authorization in which tens of thousands of people receive the vaccine to see if it is effective. Stanford plans to enroll 1,000 volunteers as part of the global trial that will include 60,000 people at 180 sites around the world.